Kinfo
MiMedx Group, Inc. logo

MiMedx Group, Inc.

MDXGNASDAQHealthcare·US · USD
$4.68
-0.01 (-0.21%)
Prices as of October 14, 2026 · live

Price

Key statistics

Valuation
Market cap684.43M USD
Enterprise value585.39M USD
Trailing P/E117.25
Forward P/E34.32
PEG ratio-0.48
Price / sales1.93
Price / book3.16
Profitability
Gross margin68.96%
Operating margin-28.69%
Profit margin1.76%
Return on assets1.91%
Return on equity2.88%
Income (TTM)
Revenue355.17M USD
Gross profit280.05M USD
EBITDA78.77M USD
Net income6.24M USD
Diluted EPS$0.04
Rev. growth (YoY)-34.70%
Balance sheet
Total cash135.84M USD
Total debt17.21M USD
Debt / equity7.97
Current ratio5.33
Book value / share$1.48
Cash flow (TTM)
Operating cash flow46.15M USD
Levered free cash flow41.43M USD
Shares & price
Shares outstanding145.72M
Float114.79M
Held by institutions77.81%
Beta1.17
50-day MA$4.52
200-day MA$4.43
52-week high$7.97
52-week low$3.03
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-280.510.56+9.80%2026-07-29-0.03-0.05−66.67%2026-06-11-0.33-0.09+72.73%2026-04-29-0.04-0.05−25.00%2026-02-250.110.14+27.27%
About MiMedx Group, Inc.

MiMedx Group, Inc. is a healthcare company focused on regenerative biologics and advanced wound care products. MiMedx Group, Inc. develops, manufactures, and markets placental tissue allografts and other biomaterial products used in wound care, surgical, burn, orthopedic, spine, sports medicine, ophthalmic, and dental applications. Its portfolio includes products derived from human placental and umbilical cord tissues, designed to support tissue repair and biologic healing in clinical settings. The company serves hospitals, physicians, and other healthcare providers through a range of wound management and surgical solutions. MiMedx Group, Inc. operates as a specialized player in the broader regenerative medicine market, with products that are used across multiple therapeutic areas where biologic tissue processing and advanced treatment options are important.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Joseph H. Capper
Employees
808
Headquarters
Marietta, GA, United States

Frequently asked questions about MiMedx Group, Inc.